Myeloablative therapy with autologous stem cell rescue for patients with Ewing sarcoma
Authors:
Open Access
- 4 February 2008
- journal article
- research article
- Published by Springer Nature in Bone Marrow Transplantation
- Vol. 41 (10) , 867-872
Abstract
The aim of this study was to identify risk factors associated with PFS in patients with Ewing sarcoma undergoing ASCT; 116 patients underwent ASCT in 1989–2000 and reported to the Center for International Blood and Marrow Transplant Research. Eighty patients (69%) received ASCT as first-line therapy and 36 (31%), for recurrent disease. Risk factors affecting ASCT were analyzed with use of the Cox regression method. Metastatic disease at diagnosis, recurrence prior to ASCT and performance score <90 were associated with higher rates of disease recurrence/progression. Five-year probabilities of PFS in patients with localized and metastatic disease at diagnosis who received ASCT as first-line therapy were 49% (95% CI 30–69) and 34% (95% CI 22–47) respectively. The 5-year probability of PFS in patients with localized disease at diagnosis, and received ASCT after recurrence was 14% (95% CI 3–30). PFS rates after ASCT are comparable to published rates in patients with similar disease characteristics treated with conventional chemotherapy, surgery and irradiation suggesting a limited role for ASCT in these patients. Therefore, ASCT if considered should be for high-risk patients in the setting of carefully controlled clinical trials.Keywords
This publication has 24 references indexed in Scilit:
- Autologous stem cell transplantation for high-risk Ewing's sarcoma and other pediatric solid tumorsBone Marrow Transplantation, 2005
- Megachemotherapy followed by autologous stem cell transplantation in children with Ewing's sarcomaPediatric Transplantation, 2005
- Treatment of Metastatic Ewing's Sarcoma or Primitive Neuroectodermal Tumor of Bone: Evaluation of Combination Ifosfamide and Etoposide—A Children's Cancer Group and Pediatric Oncology Group StudyJournal of Clinical Oncology, 2004
- Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcomaMedical and Pediatric Oncology, 2003
- Survival after recurrence of Ewing TumorsCancer, 2002
- Statistical methods for the analysis and presentation of the results of bone marrow transplants. Part 2: Regression modelingBone Marrow Transplantation, 2001
- The use of external fixators for finger injuriesThe Journal of Bone and Joint Surgery. British volume, 1998
- High-dose busulphan/melphalan with autologous stem cell rescue in Ewing’s sarcomaBone Marrow Transplantation, 1997
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958